The University of Sheffield is leading a new international programme, ASF Nexus, to improve how African swine fever (ASF) spread is predicted and prevented. The University announced it on October 22, 2026, and the veterinary news site 3tres3 republished the release on October 26.
Funding
ASF Nexus is one of 18 projects supported by a £54 million investment from the UK government and UK Research and Innovation (UKRI). The investment is co-funded by the Department for Environment, Food and Rural Affairs, the Foreign, Commonwealth and Development Office, and the Department of Health and Social Care. The release does not state ASF Nexus’s own share of the funding or the project duration.
Who is involved
The project is led by Professor Pete Dodd, Professor of Mathematical Modelling and Epidemiology at the University of Sheffield’s School of Medicine and Population Health. Partners are the University of Liverpool’s Pandemic Institute, Liverpool John Moores University, the Sarawak Infectious Disease Centre in Malaysia and Thailand’s National Centre for Genetic Engineering and Biotechnology. Professor Tuck Seng Wong, Director of the UK-SEA Vax Hub, is co-lead.
What the programme will do
ASF Nexus will study how ASF spreads and how future outbreaks can be prevented, with a focus on the UK and Southeast Asia. Research will begin in Sarawak, in Malaysian Borneo, with possible expansion across the region. The team will combine biological, economic and social research to model spread and to assess the economic impact of outbreak-response measures.
Planned outputs are open-access predictive tools, guidance for farming communities and evidence-based policy recommendations.
Dodd said: “African swine fever is one of the most serious threats facing pig farming worldwide.”
Context
The other projects in the UKRI investment address threats ranging from antimicrobial resistance to epidemic preparedness and next-generation veterinary vaccines. The release does not describe laboratory methods for ASF Nexus. Laboratory confirmation of ASF generally relies on PCR detection of viral DNA, and models of this kind need timely case reports from the laboratories that do the confirming.